Media Contact
Press Releases
- Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference November 23, 2021
- Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder November 22, 2021
- Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance November 15, 2021
- Thimble Point and Pear Therapeutics Announce Additional $50 million in Committed Capital to Fund Business Plan November 15, 2021
- Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List November 9, 2021
- Pear Therapeutics to Participate in the BTIG Digital Health Forum November 8, 2021